The brief
- The Clarity System reduces ICU stay by 4.1 days and door-to-EEG time by 19.4 hours via AI seizure detection.
- Q2 2026 revenue grew 33% YoY to $28.1M; full-year guidance of $114–117M (+28–31%).
- FDA cleared Clarity for neonatal seizure detection, the first AI EEG for all ages from newborns to adults.
Technical approach
Portable, rapidly deployable electroencephalography
The Ceribell System combines proprietary portable hardware with a simple electrode setup that enables rapid deployment in ICU settings.
AI-powered seizure detection
Clarity uses machine learning to detect electrographic seizures in real time, enabling rapid diagnosis and continuous monitoring with detection alerts.
Reducing time to diagnosis
By automating seizure detection and alerting clinicians, the system reduces the time from patient arrival to EEG interpretation and seizure detection.
